John L. Stebbins

Statistics

Publications

Citations

2.1K

H-Index

Active since

2004

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

Virginia Commonwealth University

Cedars-Sinai Medical Center

Bioscience Research

Johns Hopkins Medicine

John L. Stebbins is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2004–2019

Publications

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

John L. Stebbins, Surya K. De, Thomas Machleidt et al. · Proceedings of the National Academy of Sciences · 2008 · 188 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Standardizing Size- and Shape-Controlled Synthesis of Monodisperse Magnetite (Fe3O4) Nanocrystals by Identifying and Exploiting Effects of Organic Impurities

Liang Qiao, Zheng Fu, Ji Li et al. · ACS Nano · 2017 · 154 citations · Full text

Natural Sciences, Chemistry, Materials Science +16

Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt

Y-H Han, Xihua Cao, Bingzhen Lin et al. · Oncogene · 2006 · 143 citations

Life Sciences, Cell Biology, Molecular Biology +14

Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth

Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev et al. · Cancer Research · 2012 · 136 citations · Full text

Medicine, Oncology, Pharmacology +14

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda -7/IL-24–mediated toxicity

Rupesh Dash, Belal Azab, Bridget A. Quinn et al. · Proceedings of the National Academy of Sciences · 2011 · 124 citations

Medicine, Oncology, Pharmacology +14

1–5 of 35